학술논문

S167: PREDICTION OF RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION USING INDIVIDUALIZED MEASURABLE RESIDUAL DISEASE MARKERS; THE PROSPECTIVE NORDIC STUDY NMDSG14B.
Document Type
Article
Source
HemaSphere; 2022 Supplement 3, Vol. 6, p68-69, 2p
Subject
Language
ISSN
25729241